Most importantly, [Shari] has the right heart and mind to lead the company into even more success in the future.

ST. PAUL, Minn. (PRWEB)
June 05, 2023

Reell Precision Manufacturing, a world leader in innovative small package motion control, is pleased to announce that Shari Erdman has been promoted to the position of Co-CEO. She will share leadership responsibilities with longtime Reell CEO Kyle Smith.

Shari joined Reell in 2004 and has worked in many areas of the company including accounting, customer service, office administration, and Coworker Services. In these roles she has served in multiple capacities including sourcing, customer account management, accounting support, manufacturing process improvements, Coworker Services management, quality, and overall office administration. She also served in the position of Executive Administrative Assistant where she had opportunity to engage in the operation of the entire company. Shari served the greatest portion of her career at Reell as the VP of Global Coworker Services (HR) and for the last 14 months has served as Reell’s President.

Reell’s Board Chair Michael Naughton is pleased to have Shari in her new role. “The Board of Directors unanimously agrees that Shari is the right leader for the company, and we are delighted to see her grow her skill set and exhibit her leadership across the company. Since joining Reell Shari has served Reell in many capacities, which give her a broad understanding of Reell’ business and culture. Shari has the longest tenure of anyone on the current leadership team. Most importantly, she has the right heart and mind to lead the company into even more success in the future.”

Shari holds an MBA and a Bachelor of Science in Business Administration from the University of Northwestern. She is an active member of the Chief Executive Network, has been very active with Manufacturer’s Alliance, Women in Manufacturing (WiM), as well as other local organizations including the Midwest ESOP chapter. Shari is a native of Minnesota and will continue to serve all Reell stakeholders from Reell’s corporate headquarters in Saint Paul.

Reell Precision Manufacturing provides high-quality innovative motion control and positioning control solutions to transmit torque, control angular position and protect delicate components from excessive force. Combining the world’s most precisely controlled torque technology with the industry’s most experienced engineering team provides a perfect product fit in customer applications. Reell’s patented technology is widely used in automotive, aircraft interiors, medical technology, workstation furniture, kiosk/data terminal, consumer electronics and architectural lighting industries.

Share article on social media or email:

“We are excited about our partnership with OncoLens and the SARC Multi-Disciplinary Tumor Board,” said Dr. Scott Okuno, SARC’s chief medical officer and professor of oncology at Mayo Clinic

ATLANTA (PRWEB)
June 02, 2023

OncoLens and SARC Strategic Partnership Drives Nationwide Initiative for Enhanced Sarcoma Patient Care

Underscoring their commitment to revolutionizing cancer care, OncoLens and the Sarcoma Alliance for Research Through Collaboration (SARC) are joining forces to introduce a nationwide, virtual sarcoma tumor board, providing unprecedented access to expert-led care for this rare form of cancer

OncoLens and the Sarcoma Alliance for Research Through Collaboration (SARC) are thrilled to launch a nationwide virtual sarcoma tumor board program as part of a strategic partnership to enhance patient care. This initiative is particularly impactful for providers and patients facing limited resources while tackling sarcoma—a rare and complex form of cancer. The OncoLens Virtual Tumor Board platform will grant medical professionals across the country access to the invaluable insights of top sarcoma experts.

In the increasingly intricate landscape of cancer care, the collective knowledge of experienced clinicians is vital for making informed decisions about patient treatment. And in the case of sarcoma, the input of multiple expert clinicians is more critical than ever to ensure access and education for the physicians and surgeons treating patients on the front lines. This partnership empowers SARC with the OncoLens platform— a powerful tool that unites experts and facilitates robust virtual discussions on complex cases.

“We are excited about our partnership with OncoLens and the SARC Multi-Disciplinary Tumor Board,” said Dr. Scott Okuno, SARC’s chief medical officer and professor of oncology at Mayo Clinic, “as this allows all sarcoma providers, regardless of whether they are practicing in a small, geographically remote center or a major center, to get opinions on how to treat and manage all types of bone and soft tissue sarcoma from experts in the sarcoma field.”

The SARC Multidisciplinary Tumor Board (SMTB) brings together sarcoma experts, complementing the reach of local or regional tumor boards and providing a specialized platform for rigorous discussion of sarcoma patient cases pre- or post-diagnosis, surgery, or relapse. The SMTB provides a uniquely focused forum for physicians and surgeons to present sarcoma patient cases for in-depth, evidence-based discussion of tumor diagnosis and for managing a diverse patient population.

“In 2023 SARC proudly celebrates our twentieth year facilitating and driving team science,” said Steven Young, president and chief executive officer of SARC, “and this partnership with OncoLens helps us extend support to the broader clinical community.”

Anju Mathew, co-founder and chief executive officer of OncoLens, emphasized the transformative potential of the partnership: “We envision a world where every cancer patient has access to the best minds, therapies, and innovations in care – in time to make a difference. Collaborating with SARC helps us actualize this vision, particularly for sarcoma, which represents nearly 20% of childhood cancers and 1% of adult cancers. We’re excited about making expert-led care accessible nationwide.”

For more information, or to submit cases for consideration, clinicians are directed to: https://sarctrials.org/education/sarc-tumor-board/.

About OncoLens

OncoLens enables multidisciplinary cancer care across the continuum. Through a streamlined, secure HIPAA-compliant infrastructure, OncoLens drives intra-enterprise, community, and network participation in multidisciplinary care planning, tracking, and delivery. Using OncoLens, cancer care providers view a singular view of the patient including outpatient and in-patient clinical data, pathology, radiology, genomics and genetic information. They can collaborate on treatment plans, track quality for accreditation, and alignment to care pathways. As a result, health systems maximize clinical trial participation, an extended referral stream, and the creation of a center of excellence that can be leveraged to support patient care and provider education. More than 200 cancer centers and associations across the U.S. and internationally rely on OncoLens to support their cancer programs and the care delivered.

About SARC

SARC (Sarcoma Alliance for Research Through Collaboration) is a US-based, non-profit (501(c)(3)) organization dedicated to fostering progress in the prevention and treatment of sarcoma to improve patient outcomes and ultimately find a cure. SARC was formed by the sarcoma research community in 2003 to bring together the best cancer centers in the world supported by centralized infrastructure for the conduct of multi-institutional collaborative sarcoma research.

Since founding, SARC has fast-tracked and sponsored twenty-six Phase I, II and III clinical trials along with correlative studies to better understand the biologic bases for what drugs and combinations are most effective in treating sub-groups of patients, young investigator mentorship and grants programs, and the investigation of key biological questions across nearly 90 medical centers with specialized sarcoma programs in the United States and overseas. To learn more about the SARC organization, its impactful programs and innovative investigator-initiated clinical trials, and how to help support its mission, please visit the SARC website at http://www.sarctrials.org.

What Is Sarcoma?

Sarcomas are cancers of the bony skeleton (the skull, vertebrae, ribs, and extremities), and the so-called soft tissues, including muscle and fat. Sarcomas are disproportionately common in children and young adults but occur at all ages. There are many different types of sarcomas, leading to diagnostic and therapeutic challenges. SARC and our collaborators are working to advance the science and treatment of sarcomas.

Share article on social media or email:

Cisive Appoints Alan Gordon as President of Financial & Business Services

Alan’s in-depth understanding of our business, our clients, and our capabilities has positioned Cisive as a valuable solution partner for organizations that trust us with their background screening.

HOLTSVILLE, N.Y. (PRWEB)
June 02, 2023

Cisive, a global provider of compliance-driven human capital management and risk management solutions, announced today that longtime Cisive executive Alan Gordon will take on a new role as President, Financial & Business Services. Cisive is a portfolio company of GTCR, a leading private equity firm, which acquired the business in December 2021.

“Cisive is fortunate to welcome Alan into his new role as President of Financial and Business Services,” said Larry Neal, CEO at Cisive. “Alan’s in-depth understanding of our business, our clients, and our capabilities has positioned Cisive as a valuable solution partner for organizations that trust us with their background screening. His passion for our business, customer orientation, and engaging personal and leadership style are all very evident, and will serve him particularly well in his new role.”

As President of Financial & Business Services, Alan will lead the expansion of our business across several key vertical markets for Cisive, including financial services, transportation, and government. In addition, he will collaborate with global leadership to develop our strategy and expansion plans for our global capabilities. “I am extremely excited about my new role and am really looking forward to our very bright future,” said Alan. “Our technology, our differentiated offerings, our relentless focus on our customers and their candidates and, most of all, our employees, are all the reasons why we are on the precipice of tremendous success and growth.”

Alan joined Cisive in 2003, initially as a technology partner and provider to the business while he served as the President and CEO of CompuSmart Solutions. After CompuSmart was acquired in 2016, he joined Cisive full-time as Chief Information Officer to lead the screening firm’s technology efforts. Alan helped transform Cisive into the technology industry leader it is today. His contributions include the development of Cisive Exchange, the company’s onboarding and offboarding platform. Today, Cisive offers a flexible software product that allows custom configuration for the largest companies in the world.

For more information about Cisive and its suite of solutions, visit http://www.Cisive.com.

About Cisive

Cisive is a global leader in compliance-driven human capital and risk management solutions, providing onboarding and pre-employment background screening solutions to address large enterprises’ complex challenges and needs with dedicated, in-country account management teams committed to customer satisfaction. Cisive is accredited by the Professional Background Screeners Association (PBSA) and was named for the sixth consecutive year by HRO Today to the 2022 Baker’s Dozen Customer Satisfaction rankings of Top Pre-Employment Screening Providers, in addition to being named Company of the Year by CIO Review. The company and its brands serve clients in financial services, transportation, telecom/media, healthcare, utilities, and home services end-markets, among others. For additional information, please visit http://www.cisive.com.

Share article on social media or email:

RFT’s Fall Detection Solutions Options Graphic for Sensors, Wearables, and Pads

“RF Technologies is committed to providing the most advanced and reliable fall management solutions to senior living communities and health systems,” said Paul Larson, VP New Product Development and Engineering Services of RF Technologies.

BROOKFIELD, Wis. (PRWEB)
June 02, 2023

RF Technologies (RFT), a leading provider of healthcare and senior living safety and security solutions, has announced the expansion of its Code Alert Quick Response Fall Management Solutions portfolio (http://www.rft.com). The expanded portfolio offers three options for fall detection, including a highly accurate sensor-based technology, a wearable pendant, and a cost-effective sensor pad.

Falls are a significant concern for residents in senior living communities, and preventing falls is a top priority for caregivers. RF Technologies’ Code Alert Quick Response Fall Management Solutions provide reliable and customizable options to ensure that caregivers are alerted quickly in the event of a fall.

“RF Technologies is committed to providing the most advanced and reliable fall management solutions to senior living communities and health systems,” said Paul Larson, VP New Product Development and Engineering Services of RF Technologies. “We understand that preventing falls is a top priority for caregivers, and our expanded portfolio of fall management solutions provides reliable options that can be customized to meet the needs of each and every resident.”

The first option in the fall solutions portfolio is an unprecedented, highly accurate sensor-based technology that uses camera-free radio frequency technology to provide 24/7 touchless monitoring. This option delivers real-time fall detection that works in all lighting conditions, dense steam, and high humidity while protecting people and respecting their individual privacy. The system is integrated with RFT’s nurse call systems for added convenience and alerting through Code Alert Enterprise-enabled devices.

The second option in the fall solutions portfolio is a mobile, wearable technology worn by the resident on a pendant. The wearable solution uses accelerometers to detect falls and sends an automatic alert to caregivers via Code Alert Enterprise-enabled devices. This option is ideal for residents who are more active or mobile as it includes technology that enables advanced location features. The device also includes a highly visible button that activates nurse call.

The third option in the fall solutions portfolio is a cost-effective, disposable sensor pad that is placed on the patient or resident’s mattress or chair. The sensor pad detects changes in pressure and alerts caregivers if the patient or resident gets out of bed or a chair. This option is ideal for those who are less active or have limited mobility. Further, the device works right out of the box, with the optional ability to tie into existing nurse call systems.

For more information about RF Technologies’ Code Alert Quick Response Fall Management Solutions, please visit the company’s fall management webpage at https://www.rft.com/fall-management/.

For questions or inquiries, please contact the RFT marketing department at marcomm@rft.com.

About RF Technologies

RF Technologies is a leading provider of healthcare, senior living, education, and hospitality safety and security solutions. The company’s comprehensive senior living solutions portfolio includes wireless nurse call systems, wander management solutions, and fall management solutions. RF Technologies is committed to providing innovative and reliable solutions that help communities improve resident safety and enhance caregiver efficiency.

Share article on social media or email: